NEVRO CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.33 USD | -0.21% |
|
-2.00% | -56.64% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,645 | 5,960 | 2,830 | 1,403 | 780.4 | 343.4 | - | - |
| Enterprise Value (EV) 1 | 3,567 | 5,682 | 2,619 | 1,216 | 669.2 | 251.2 | 262 | 272.1 |
| P/E ratio | -34.9 x | -70.1 x | -21.5 x | 495 x | -8.41 x | -4.04 x | -4.46 x | -5.24 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 9.34 x | 16.5 x | 7.31 x | 3.45 x | 1.84 x | 0.78 x | 0.74 x | 0.7 x |
| EV / Revenue | 9.14 x | 15.7 x | 6.77 x | 2.99 x | 1.57 x | 0.57 x | 0.56 x | 0.55 x |
| EV / EBITDA | -43.5 x | -1,473 x | -152 x | -51.1 x | -37.8 x | -142 x | 32.3 x | 13.8 x |
| EV / FCF | -66.4 x | -1,175 x | -48.3 x | 70.9 x | -9.93 x | -86.6 x | -24 x | 30.2 x |
| FCF Yield | -1.51% | -0.09% | -2.07% | 1.41% | -10.1% | -1.15% | -4.16% | 3.31% |
| Price to Book | 17.1 x | 15.4 x | 9.35 x | 4.34 x | 2.67 x | 1.38 x | 1.6 x | 1.35 x |
| Nbr of stocks (in thousands) | 31,007 | 34,429 | 34,904 | 35,430 | 36,266 | 36,729 | - | - |
| Reference price 2 | 117.5 | 173.1 | 81.07 | 39.60 | 21.52 | 9.350 | 9.350 | 9.350 |
| Announcement Date | 2/25/20 | 2/24/21 | 2/23/22 | 2/16/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 390.3 | 362 | 386.9 | 406.4 | 425.2 | 439.9 | 464.3 | 492.3 |
| EBITDA 1 | -82.02 | -3.857 | -17.19 | -23.79 | -17.7 | -1.769 | 8.103 | 19.79 |
| EBIT 1 | -86.74 | -62.85 | -110.9 | 6.164 | -99.31 | -88.78 | -73.08 | -54.9 |
| Operating Margin | -22.23% | -17.36% | -28.67% | 1.52% | -23.36% | -20.18% | -15.74% | -11.15% |
| Earnings before Tax (EBT) 1 | -102.1 | -82.2 | -130.8 | 4.264 | -97.86 | -82.03 | -75.65 | -63.53 |
| Net income 1 | -103.7 | -83.06 | -131.4 | 3.001 | -92.21 | -83.99 | -77.44 | -67.36 |
| Net margin | -26.57% | -22.94% | -33.95% | 0.74% | -21.69% | -19.09% | -16.68% | -13.68% |
| EPS 2 | -3.370 | -2.470 | -3.770 | 0.0800 | -2.560 | -2.312 | -2.096 | -1.786 |
| Free Cash Flow 1 | -53.7 | -4.834 | -54.22 | 17.13 | -67.42 | -2.9 | -10.9 | 9 |
| FCF margin | -13.76% | -1.34% | -14.01% | 4.22% | -15.86% | -0.66% | -2.35% | 1.83% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 45.48% |
| FCF Conversion (Net income) | - | - | - | 570.91% | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/25/20 | 2/24/21 | 2/23/22 | 2/16/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 102.8 | 87.84 | 104.2 | 100.5 | 113.8 | 96.33 | 108.8 | 103.9 | 116.2 | 101.9 | 107.1 | 107.6 | 123.1 | 106.7 | 113.9 |
| EBITDA 1 | -7.513 | -14.06 | -4.491 | -3.795 | -1.441 | -17.14 | -3.125 | -5.795 | 8.366 | -9.596 | -2.799 | -0.7131 | 10.7 | -10.56 | -0.4107 |
| EBIT 1 | -26.22 | -32.77 | -23.79 | 82.08 | -19.36 | -36.32 | -25.64 | -25.56 | -11.79 | -35.83 | -24.47 | -20.56 | -10.43 | -30.93 | -20.29 |
| Operating Margin | -25.51% | -37.3% | -22.83% | 81.7% | -17% | -37.71% | -23.56% | -24.61% | -10.15% | -35.17% | -22.84% | -19.1% | -8.47% | -28.99% | -17.82% |
| Earnings before Tax (EBT) 1 | -30.21 | -34.14 | -24.75 | 81.99 | -18.84 | -34.7 | -24.25 | -23.35 | -15.56 | -25.03 | -26.43 | -21.98 | -12.22 | -32.55 | -23.26 |
| Net income 1 | -30.13 | -34.32 | -24.99 | 81.51 | -19.19 | -35.03 | -24.72 | -23.48 | -8.981 | -25.41 | -25.96 | -21.87 | -11.68 | -31.57 | -23.57 |
| Net margin | -29.32% | -39.08% | -23.98% | 81.13% | -16.86% | -36.36% | -22.72% | -22.61% | -7.73% | -24.94% | -24.23% | -20.32% | -9.48% | -29.59% | -20.7% |
| EPS 2 | -0.8600 | -0.9800 | -0.7100 | 2.220 | -0.5400 | -0.9800 | -0.6900 | -0.6500 | -0.2500 | -0.7000 | -0.7040 | -0.5827 | -0.3128 | -0.8033 | -0.6075 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/23/22 | 5/4/22 | 8/3/22 | 11/2/22 | 2/16/23 | 4/26/23 | 8/1/23 | 11/1/23 | 2/21/24 | 5/7/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 77.5 | 277 | 211 | 188 | 111 | 92.3 | 81.4 | 71.3 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -53.7 | -4.83 | -54.2 | 17.1 | -67.4 | -2.9 | -10.9 | 9 |
| ROE (net income / shareholders' equity) | -44.9% | -27.5% | -38% | -20% | -23.7% | -26.7% | -33.6% | -34.2% |
| ROA (Net income/ Total Assets) | -22.2% | -13.2% | -12.6% | -10.7% | -11.8% | -15.5% | -18.6% | -18.9% |
| Assets 1 | 466.4 | 629.5 | 1,039 | -28.09 | 782.1 | 541.9 | 416.4 | 356.4 |
| Book Value Per Share 2 | 6.860 | 11.20 | 8.670 | 9.120 | 8.060 | 6.780 | 5.840 | 6.910 |
| Cash Flow per Share 2 | -1.630 | 0.0400 | - | 0.6900 | -1.640 | -0.2100 | 0.6300 | - |
| Capex 1 | 3.47 | 6.03 | 12.3 | 7.54 | 8.59 | 8 | 11.4 | 13 |
| Capex / Sales | 0.89% | 1.66% | 3.19% | 1.86% | 2.02% | 1.82% | 2.46% | 2.65% |
| Announcement Date | 2/25/20 | 2/24/21 | 2/23/22 | 2/16/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
9.35
USD
Average target price
14.8
USD
Spread / Average Target
+58.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -56.55% | 343M | |
| -7.16% | 178B | |
| -1.23% | 107B | |
| -4.86% | 67.04B | |
| -4.28% | 47.23B | |
| +10.32% | 44.62B | |
| +9.19% | 42.5B | |
| +16.46% | 25.22B | |
| -5.88% | 24.14B | |
| -5.38% | 23.69B |
- Stock Market
- Equities
- NVRO Stock
- Financials Nevro Corp.
